STOCK TITAN

Kindly Md, Inc. SEC Filings

NAKA Nasdaq

Welcome to our dedicated page for Kindly Md SEC filings (Ticker: NAKA), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Kindly Md's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.

Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Kindly Md's regulatory disclosures and financial reporting.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
prospectus
-
Rhea-AI Summary

Jared Barrera, Chief Financial Officer of Kindly MD, Inc. (NAKA), reported a restricted stock award that fully vested on 09/22/2025, resulting in an acquisition of 6,400 shares at no cash price and increasing his beneficial ownership to 22,242 shares. The Form 4, filed by attorney-in-fact on 09/24/2025, shows the transaction was an internal equity award rather than an open-market purchase or sale. The filing includes a standard Exhibit 24 power of attorney signature and does not disclose any cash consideration, option exercises, or derivative transactions.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Kindly MD, Inc. (NAKA) insider reported multiple grants to Chief Medical Officer Timothy Pickett on 09/22/2025. The Form 4 shows four non‑derivative transactions reporting the receipt of 37,593 restricted stock units that vest over four years with a 12‑month cliff, plus three fully vested restricted stock awards of 26,129, 10,146, and 18,378 shares, bringing reported beneficial ownership to 191,271 shares after the transactions. All grants were reported with a $0 price, indicating they are equity awards rather than market purchases. The filing is signed by an attorney‑in‑fact on behalf of the reporting person.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Eric Stanton Weiss, a director of Kindly MD, Inc. (NAKA), was granted 112,781 restricted stock units (RSUs) reported on a Form 4 with a transaction date of 09/22/2025. The RSUs were recorded at a price of $0 and are shown as directly beneficially owned following the grant. The RSUs vest on August 15, 2026 and are subject to Mr. Weiss’s continued service on the company’s board through that Vesting Date. The Form 4 was signed on behalf of the reporting person by an attorney-in-fact, Kyle Simon, on 09/24/2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Kindly MD, Inc. (NAKA) director Gregory Elias Xethalis was reported as the sole reporting person on a Form 4 disclosing an award of 112,781 restricted stock units (RSUs) on 09/22/2025. The RSUs are non‑cash, granted at $0 price and are scheduled to vest on August 15, 2026, subject to his continued service on the board through the vesting date. After the reported transaction the filing shows 112,781 shares beneficially owned by the reporting person. The Form is signed by an attorney‑in‑fact on behalf of the reporting person on 09/24/2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Amanda Fabiano, Chief Operating Officer of Kindly MD, Inc. (NAKA), reported two grants of restricted stock units on 09/22/2025 that increase her direct beneficial ownership to 4,135,337 shares. One grant covers 751,879 RSUs and the second covers 3,383,458 RSUs; both show a transaction price of $0 and are time-vesting over three years with a 12-month cliff beginning August 15, 2025. After the cliff, 25% vests immediately and the remaining 75% vests in equal quarterly installments over the following 24 months, subject to continued service. The larger grant is further contingent on a performance condition: no shares will vest under that grant unless Fabiano causes Second Gate Advisory, LLC (an entity she owns and controls) to assign or transfer certain business arrangements to the issuer. The Form 4 was signed by an attorney-in-fact on 09/24/2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Kindly MD, Inc. (NAKA) reports a grant of 751,879 restricted stock units (RSUs) to reporting person David F. Bailey in a transaction dated 09/22/2025. The RSUs vest over four years with a 12-month cliff measured from August 15, 2025: 25% vests at the end of the cliff and the remaining 75% vests in equal quarterly installments over the following 36 months, subject to continued service. After this grant the reporting person beneficially owns 11,912,451 shares. The RSUs have no purchase price reported and are time-based equity compensation intended to align executive incentives with shareholder outcomes.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Kindly MD, Inc. (NAKA) insider report: Chief Commercial Officer Andrew Creighton was granted 601,503 restricted stock units (RSUs) that will time-vest over four years. There is a 12-month cliff from August 15, 2025, after which 25% vests at cliff completion and the remaining 75% vests in equal quarterly installments over the following 36 months, contingent on continued service. After the grant, Mr. Creighton beneficially owns 3,726,474 shares of common stock. The RSUs were granted at no cash price to the reporting person and are subject to the issuer’s standard vesting and service conditions.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Tyler Matthew Evans, Chief Investment Officer of Kindly MD, Inc. (NAKA), was granted 601,503 restricted stock units (RSUs) on 09/22/2025 at a reported price of $0, bringing his total beneficial ownership to 3,012,188 shares. The RSUs vest over four years with a 12-month cliff beginning August 15, 2025, after which 25% vest at the cliff and the remaining 75% vest in equal quarterly installments over the following 36 months. Vesting is contingent on the reporting person’s continued service through each vesting date. The Form 4 was signed by an attorney-in-fact on 09/24/2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider

FAQ

What is the current stock price of Kindly Md (NAKA)?

The current stock price of Kindly Md (NAKA) is $1.17 as of September 29, 2025.

What is the market cap of Kindly Md (NAKA)?

The market cap of Kindly Md (NAKA) is approximately 432.5M.
Kindly Md, Inc.

Nasdaq:NAKA

NAKA Rankings

NAKA Stock Data

432.54M
347.02M
5.96%
0.22%
0.39%
Medical Care Facilities
Services-health Services
Link
United States
SALT LAKE CITY